0001209191-11-031297.txt : 20110526
0001209191-11-031297.hdr.sgml : 20110526
20110526164857
ACCESSION NUMBER: 0001209191-11-031297
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110525
FILED AS OF DATE: 20110526
DATE AS OF CHANGE: 20110526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER KENNETH S
CENTRAL INDEX KEY: 0001046336
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 11874667
MAIL ADDRESS:
STREET 1: C/O ECOSCIENCE CORP
STREET 2: 10 ALVIN COURT
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-05-25
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001046336
BOGER KENNETH S
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02176
0
1
0
0
SVP & General Counsel
Common Stock
2011-05-25
4
S
0
1577
55.56
D
115488
D
Common Stock
2011-05-25
4
S
0
2489
56.23
D
112999
D
Common Stock
5021
I
401(k)
Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $55.56 (range $55.14 to $55.95).
Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $56.23 (range $56.01 to $56.46).
Kenneth S. Boger
2011-05-26